학술논문
A PHASE 1B STUDY OF ZOTATIFIN FOR THE TREATMENT OF MILD TO MODERATE COVID (PROpel).
Document Type
Article
Author
Source
Topics in Antiviral Medicine; Apr2023, Vol. 31 Issue 2, p214-214, 1/3p
Subject
Language
ISSN
21615861